2021
DOI: 10.3748/wjg.v27.i31.5171
|View full text |Cite
|
Sign up to set email alerts
|

Molecular advances in pancreatic cancer: A genomic, proteomic and metabolomic approach

Abstract: Pancreatic ductal adenocarcinoma (PDAC) represents a challenging pathology with very poor outcomes and is increasing in incidence within the general population. The majority of patients are diagnosed incidentally with insidious symptoms and hence present late in the disease process. This significantly affects patient outcomes: the only cure is surgical resection but only up to 20% of patients present with resectable disease at the time of clinical presentation. The use of “omic” technology is expanding rapidly… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 32 publications
0
5
0
Order By: Relevance
“…Work in genomics, proteomics, and metabolomics to identify resistance or susceptibility to chemotherapy drugs has the potential to maximize treatment benefits and minimize treatment-related toxicity. 37…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Work in genomics, proteomics, and metabolomics to identify resistance or susceptibility to chemotherapy drugs has the potential to maximize treatment benefits and minimize treatment-related toxicity. 37…”
Section: Discussionmentioning
confidence: 99%
“…Work in genomics, proteomics, and metabolomics to identify resistance or susceptibility to chemotherapy drugs has the potential to maximize treatment benefits and minimize treatment-related toxicity. 37 One of the drawbacks to NACRT is its toxicity and potential to delay curative surgery, especially in patients who have resectable disease. Both FOLFIRINOX and gemcitabine are toxic, and comparisons of their toxicities vary in their results.…”
Section: Discussionmentioning
confidence: 99%
“…Nonetheless, little is still known about the tumorigenesis of PDAC in these individuals [ 83 ]. Whole genome sequencing studies may help to understand the carcinogenesis of these interval cases [ 84 ].…”
Section: Outcomes Of High-risk Individuals Undergoing Pancreatic Canc...mentioning
confidence: 99%
“…The molecules that the omics studied give it the name: metabolomics, proteomics, metabolomics, genomics, etc. (Rajesh et al, 2021).…”
Section: Omics: Understanding the Biological Systemsmentioning
confidence: 99%

CIERMMI Women in Science T-XVIII Health Sciences

MARROQUÍN-DE JESÚS,
MORALES-HERNÁNDEZ,
RAMÍREZ-BALTAZAR
et al. 2022